Author Archive: George Goodno

George Goodno

George is the Director of State Policy Communications at BIO and enjoys the opportunity to advocate for and educate audiences about the positive societal and economic impact of the bioscience industry. Another great aspect of his job is getting to work with BIO’s broad network of state bioscience associations to help advance legislative and regulatory initiatives that will continue to improve this high-skill, high-wage industry. In his spare time, he enjoys running, skiing, hiking, gardening, and most of all, spending time with his awesome wife and two daughters.

Follow him on Twitter @ggoodno

 

Latest Posts

Virginia Bio Announces Conference Featuring Gov. McAuliffe

vabio

Virginia Bio has announced that its bioscience centered THRiVE 2015 Conference will feature a Governor’s Forum on Bio and Big Data/Analytics. “We are proud to present this opportunity for direct interaction with some of the most influential thought leaders in the bioscience industry.” Jeffrey M. Gallagher, CEO, Virginia Bio Click Here to Register Virginia’s own Governor Terry McAuliffe will be on hand, as will bioscience leaders from across the state and beyond – including companies, universities, Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , ,

BIO Asia International Conference Kicks Off Today

logo

The 12th Annual BIO Asia International Conference kicks off today (or tomorrow based on your time zone). The conference features private, pre-arranged one-on-one meetings between senior-level executives, using BIO’s proprietary, state-of-the-art computer software. The format and selective nature of the conference makes this the premier dedicated biotech partnering event in Asia and an unrivaled opportunity to meet with the leading international pharmaceutical and biotech companies in one place at one time. To see the most Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , ,

BIO Chair Testifies Before Senate

BIO’s Chair and CEO of GlycoMimetics, Rachel King

BIO’s Chair and CEO of GlycoMimetics, Rachel King, testified before the Senate Committee on Small Business and Entrepreneurship today where she reinforced the need for patent protection incentives to encourage small business innovation. Ms. King also encouraged Congress to address weaknesses in the United States Patent and Trademark Office’s Inter Partes Review (IRP) system that allows abuses perpetrated against legitimate patent holders. Read her full testimony. You can read more about BIO’s position on patent Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , ,

Kyle Bass Files Second IPR Petition

Attribution: Vlad Lazarenko via Wikimedia Commons

Today hedge fund manager Kyle Bass has continued his reported “short activist strategy” campaign by filing a second Inter Partes Review (IPR) petition with the U.S. Patent and Trademark Office (USPTO). BIO expressed grave concerns with this exploitation of the patent challenge system following Mr. Bass’ initial filing earlier this month. Follow the below links to read more. BIO’s prior statement issued following Kyle Bass’ first IPR Petition When The Deck is Stacked Against Innovators, Everyone Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , ,

Seizing Academic Breakthroughs in Japan

Asia2013_115x76_Thumbnail copy

Japanese universities and universities around the Asia Pacific region are entering into unique evolving partnerships with biopharmaceutical companies. Universities are also exploring incubator and other models with company partners to deliver the next wave of biotechnology innovations. With a focus on collaborative projects between industry and academia, this year’s BIO Asia conference will attract universities and national/public institutes and their biopharma partners to come together to discuss their latest partnering models, an integral growth opportunity Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,